Kennedy Capital Management’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-548
Closed -$51K 617
2022
Q3
$51K Sell
548
-1
-0.2% -$107 ﹤0.01% 605
2022
Q2
$67K Sell
549
-5
-0.9% -$587 ﹤0.01% 594
2022
Q1
$65K Sell
554
-85
-13% -$14.1K ﹤0.01% 596
2021
Q4
$166K Sell
639
-1,154
-64% -$351K ﹤0.01% 608
2021
Q3
$489K Buy
+1,793
New +$517K 0.01% 581

Other funds holding DRIO

Kennedy Capital Management's DRIO Position: Q4 2022 in Review

Kennedy Capital Management sold out of DarioHealth (DRIO) in Q4 2022, closing a stake of 548 shares — an estimated $51K sold.

Kennedy Capital Management first reported a position in DRIO in Q3 2021 and held it in 5 quarters. The position peaked at $489K in Q3 2021. 47 funds tracked by Wall St. Rank hold DRIO as of Q4 2022.

  • Kennedy Capital Management reported no remaining DarioHealth position as of Q4 2022 after selling out during the quarter.
  • Kennedy Capital Management sold 548 DarioHealth shares in Q4 2022, an estimated $51K.
  • Kennedy Capital Management first reported a position in DarioHealth in Q3 2021 and held it in 5 quarters.
  • Kennedy Capital Management's DarioHealth position peaked at $489K in Q3 2021.
  • 47 funds tracked by Wall St. Rank held DarioHealth as of Q4 2022.

Based on Kennedy Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.